KOCAA
BPMC

Knights of Columbus Asset Advisors’s Blueprint Medicines BPMC Stock Holding History

Knights of Columbus Asset Advisors’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-4,752
Closed -$609K – 383
2025
Q2 		$609K Sell
4,752
-8,243
-63% -$856K 0.04% 272
2025
Q1 		$1.15M Buy
12,995
+343
+3% +$33.5K 0.08% 227
2024
Q4 		$1.1M Buy
+12,652
New +$1.16M 0.07% 237

Other funds holding BPMC

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Knights of Columbus Asset Advisors's BPMC Position: Q3 2025 in Review

Knights of Columbus Asset Advisors sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 4,752 shares — an estimated $609K sold.

Knights of Columbus Asset Advisors first reported a position in BPMC in Q4 2024 and held it in 3 quarters. The position peaked at $1.15M in Q1 2025. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.

  • Knights of Columbus Asset Advisors reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
  • Knights of Columbus Asset Advisors sold 4,752 Blueprint Medicines shares in Q3 2025, an estimated $609K.
  • Knights of Columbus Asset Advisors first reported a position in Blueprint Medicines in Q4 2024 and held it in 3 quarters.
  • Knights of Columbus Asset Advisors's Blueprint Medicines position peaked at $1.15M in Q1 2025.
  • 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.

Based on Knights of Columbus Asset Advisors's 13F filing for Q3 2025, filed 3 Nov 2025.